BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Midodrine

An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.

300+ PubMed studies analyzed · 49 RCTs · Evidence Score: 55.4

Research Domains

Midodrine has been studied across 9 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🫁 Liver & Detox, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Midodrine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Aztreonam
4 shared targets
Pinacidil
4 shared targets
Metaraminol
4 shared targets
Modafinil
4 shared targets
Sulfadoxine
4 shared targets
Felbamate
4 shared targets
idebenone
3 shared targets
Nateglinide
4 shared targets
Carbimazole
3 shared targets
Mephenytoin
2 shared targets
Loading evidence profile...

This evidence profile for Midodrine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.